Cargando…
Early Diagnosis of Brain Metastases Using a Biofluids-Metabolomics Approach in Mice
Over 20% of cancer patients will develop brain metastases. Prognosis is currently extremely poor, largely owing to late-stage diagnosis. We hypothesized that biofluid metabolomics could detect tumours at the micrometastatic stage, prior to the current clinical gold-standard of blood-brain barrier br...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ivyspring International Publisher
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135440/ https://www.ncbi.nlm.nih.gov/pubmed/27924154 http://dx.doi.org/10.7150/thno.16538 |